BillTrack50 logo
Free Signup Login
Bill

Bill > HR1266

US HR1266

US HR1266
Combating Illicit Xylazine Act

summary

Introduced
02/12/2025
In Committee
07/21/2026
Crossed Over
Passed
Dead

Introduced Session

119th Congress

Bill Summary

A BILL To prohibit certain uses of xylazine, and for other purposes.

AI Summary

This bill addresses the regulation of xylazine, a veterinary sedative that has increasingly been used illicitly in drug mixtures. The bill first defines xylazine comprehensively, including its salts and isomers, and adds it to Schedule III of the Controlled Substances Act, which means it will be subject to federal drug control regulations. The legislation establishes specific rules for xylazine's use, primarily limiting its possession to veterinarians, registered pharmacies, and specific contexts like animal control and wildlife programs. The bill provides a transition period for manufacturers and practitioners, giving them time to adapt to the new regulations, and requires the Drug Enforcement Administration and Food and Drug Administration to expedite the necessary administrative processes. Additionally, the bill mandates two reports to Congress - an initial report within 18 months examining xylazine's prevalence, diversion, origin, and potential abuse risks, and a follow-up report after four years updating Congress on trafficking and misuse trends. The United States Sentencing Commission is also directed to review and potentially amend sentencing guidelines to provide appropriate penalties for offenses involving xylazine, taking into account its use alongside other controlled substances.

Committee Categories

Business and Industry, Health and Social Services

Sponsors (114)

Jimmy Panetta (D)*,  Mark Alford (R),  Jake Auchincloss (D),  Don Bacon (R),  Jim Baird (R),  Troy Balderson (R),  Nanette Barragán (D),  Cliff Bentz (R),  Jack Bergman (R),  Stephanie Bice (R),  Sheri Biggs (R),  Gus Bilirakis (R),  Nikki Budzinski (D),  Tim Burchett (R),  Ken Calvert (R),  Mike Carey (R),  Buddy Carter (R),  Sheila Cherfilus-McCormick (D),  Juan Ciscomani (R),  Yvette Clarke (D),  Steve Cohen (D),  Mike Collins (R),  Lou Correa (D),  Jim Costa (D),  Angie Craig (D),  Dan Crenshaw (R),  Sharice Davids (D),  Don Davis (D),  Monica De La Cruz (R),  Madeleine Dean (D),  Suzan DelBene (D),  Chris Deluzio (D),  Scott DesJarlais (R),  Chuck Edwards (R),  Gabe Evans (R),  Brad Finstad (R),  Michelle Fischbach (R),  Scott Fitzgerald (R),  Brian Fitzpatrick (R),  Vince Fong (R),  Valerie Foushee (D),  John Garamendi (D),  Laura Gillen (D),  Marie Gluesenkamp Pérez (D),  Craig Goldman (R),  Maggie Goodlander (D),  Josh Gottheimer (D),  Adam Gray (D),  Glenn Grothman (R),  Josh Harder (D),  Mike Haridopolos (R),  Andy Harris (R),  Diana Harshbarger (R),  Pablo Jose Hernandez (D),  Glenn Ivey (D),  Ronny Jackson (R),  Dusty Johnson (R),  John Joyce (R),  Robin Kelly (D),  Timothy Kennedy (D),  Young Kim (R),  Brad Knott (R),  Nick Langworthy (R),  Laurel Lee (R),  Julia Letlow (R),  Zoe Lofgren (D),  Frank Lucas (R),  Ryan Mackenzie (R),  Seth Magaziner (D),  Tracey Mann (R),  Sarah McBride (D),  Kristen McDonald Rivet (D),  Addison McDowell (R),  Mariannette Miller-Meeks (R),  Dave Min (D),  Tim Moore (R),  Troy Nehls (R),  Donald Norcross (D),  Zach Nunn (R),  Jay Obernolte (R),  Chris Pappas (D),  Scott Peters (D),  Brittany Pettersen (D),  August Pfluger (R),  Josh Riley (D),  Deborah Ross (D),  David Rouzer (R),  Michael Rulli (R),  Andrea Salinas (D),  Derek Schmidt (R),  Hillary Scholten (D),  Kim Schrier (D),  Keith Self (R),  Terri Sewell (D),  Mike Simpson (R),  Chris Smith (R),  Eric Sorensen (D),  Darren Soto (D),  Bryan Steil (R),  Tom Suozzi (D),  Claudia Tenney (R),  Mike Thompson (D),  Dina Titus (D),  Jill Tokuda (D),  Lori Trahan (D),  Jeff Van Drew (R),  Beth Van Duyne (R),  Derrick Van Orden (R),  Gabe Vasquez (D),  Eugene Vindman (D),  Randy Weber (R),  Daniel Webster (R),  Rob Wittman (R),  Rudy Yakym (R), 

Last Action

Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 48 - 0. (on 07/21/2026)

Bill Topics

Health
  • ‐ Drug Abuse, Treatment, and Education
  • ‐ Regulation of Drug Industry and Pharmacies
Law, Crime, and Family Issues
  • ‐ Criminal and Juvenile Delinquent Prosecution, Procedure, and Sentencing
  • ‐ Illegal Drugs and Narcotics Control
(2 Companion Bills)

bill text

bill summary

Loading...

bill summary

Loading...

bill summary

Document Type Source Location Created
State Bill Page https://www.congress.gov/bill/119th-congress/house-bill/1266/all-info 02/13/2025
BillText https://www.congress.gov/119/bills/hr1266/BILLS-119hr1266ih.pdf 03/13/2025
Loading...